Longitudinal comparison of health-related quality of life at 3 and 12 months post-stroke using patient-reported outcome measures

IF 2.1 4区 医学 Q3 NEUROSCIENCES
Hojin Ju MD , Won Kee Chang MD, MS , Hee-Mun Cho MD , Hyo Jong Kim MD , Miji Kang RN , Yun-Sun Jung MPH, PhD , Nam-Jong Paik MD, PhD , Won-Seok Kim MD, PhD
{"title":"Longitudinal comparison of health-related quality of life at 3 and 12 months post-stroke using patient-reported outcome measures","authors":"Hojin Ju MD ,&nbsp;Won Kee Chang MD, MS ,&nbsp;Hee-Mun Cho MD ,&nbsp;Hyo Jong Kim MD ,&nbsp;Miji Kang RN ,&nbsp;Yun-Sun Jung MPH, PhD ,&nbsp;Nam-Jong Paik MD, PhD ,&nbsp;Won-Seok Kim MD, PhD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108559","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Health-related quality of life (HRQoL) is a key outcome in stroke survivors, but evidence on distinct physical and mental recovery trajectories is limited. EuroQoL 5-dimension 3-level (EQ-5D-3L) is widely used but prone to ceiling effects and cannot separate physical (PH) and mental health (MH). We administered Patient-Reported Outcomes Measurement Information System 10-item short form (PROMIS-10) at 3 and 12 months post-stroke, identified discharge-related predictors of PROMIS-10 PH and MH to distinguish their recovery trajectories, and compared their discriminatory capacity with that of EQ-5D-3L.</div></div><div><h3>Methods</h3><div>We analyzed PROMIS-10 and EQ-5D-3L scores in a retrospective cohort of 741 stroke survivors discharged from a tertiary center and followed at 3 and 12 months. Discriminatory capacity across modified Rankin Scale (mRS) groups was assessed using effect sizes. Linear regression identified demographic and clinical predictors of PROMIS-10 PH and MH at 3 and 12 months.</div></div><div><h3>Results</h3><div>At 3 months, EQ-5D-3L demonstrated greater discriminatory capacity across mRS groups. At 12 months, PH exhibited better discriminatory capacity than EQ-5D-3L for mild disability (mRS 0–1 vs. 2), consistent with ceiling effects reducing EQ-5D-3L sensitivity in the mild impairment group. Discharge ambulation consistently predicted both PH and MH at 3 and 12 months. Comorbidity burden, employment status, respondent type (proxy vs. patient), and discharge destination were associated with PROMIS-10, particularly in 12-month MH.</div></div><div><h3>Conclusion</h3><div>Predictors and trajectories differed between PH and MH groups, supporting separate assessment. PROMIS-10 exhibited better discriminatory capacity of milder disability at 12 months by distinguishing physical and mental dimensions, supporting tailored care basis.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108559"},"PeriodicalIF":2.1000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305726000200","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Health-related quality of life (HRQoL) is a key outcome in stroke survivors, but evidence on distinct physical and mental recovery trajectories is limited. EuroQoL 5-dimension 3-level (EQ-5D-3L) is widely used but prone to ceiling effects and cannot separate physical (PH) and mental health (MH). We administered Patient-Reported Outcomes Measurement Information System 10-item short form (PROMIS-10) at 3 and 12 months post-stroke, identified discharge-related predictors of PROMIS-10 PH and MH to distinguish their recovery trajectories, and compared their discriminatory capacity with that of EQ-5D-3L.

Methods

We analyzed PROMIS-10 and EQ-5D-3L scores in a retrospective cohort of 741 stroke survivors discharged from a tertiary center and followed at 3 and 12 months. Discriminatory capacity across modified Rankin Scale (mRS) groups was assessed using effect sizes. Linear regression identified demographic and clinical predictors of PROMIS-10 PH and MH at 3 and 12 months.

Results

At 3 months, EQ-5D-3L demonstrated greater discriminatory capacity across mRS groups. At 12 months, PH exhibited better discriminatory capacity than EQ-5D-3L for mild disability (mRS 0–1 vs. 2), consistent with ceiling effects reducing EQ-5D-3L sensitivity in the mild impairment group. Discharge ambulation consistently predicted both PH and MH at 3 and 12 months. Comorbidity burden, employment status, respondent type (proxy vs. patient), and discharge destination were associated with PROMIS-10, particularly in 12-month MH.

Conclusion

Predictors and trajectories differed between PH and MH groups, supporting separate assessment. PROMIS-10 exhibited better discriminatory capacity of milder disability at 12 months by distinguishing physical and mental dimensions, supporting tailored care basis.
卒中后3个月和12个月健康相关生活质量的纵向比较
背景:与健康相关的生活质量(HRQoL)是脑卒中幸存者的一个关键结果,但关于明显的身体和精神恢复轨迹的证据有限。EuroQoL 5维3级(EQ-5D-3L)被广泛使用,但容易产生天花板效应,不能将身体(PH)和精神健康(MH)分开。我们在脑卒中后3个月和12个月使用了患者报告结果测量信息系统10项短表(promise -10),确定了与出院相关的promise -10 PH和MH预测因子,以区分其恢复轨迹,并将其与EQ-5D-3L的区分能力进行了比较。方法:我们分析了741名从三级中心出院的中风幸存者的promise -10和EQ-5D-3L评分,并在3个月和12个月进行了随访。采用效应量评估改良兰金量表(mRS)组的歧视能力。线性回归确定了3个月和12个月时promise -10 PH和MH的人口学和临床预测因子。结果:在3个月时,EQ-5D-3L在mRS组中表现出更大的歧视能力。在12个月时,PH对轻度残疾表现出比EQ-5D-3L更好的区分能力(mRS 0-1 vs. 2),这与天花板效应降低轻度损伤组EQ-5D-3L的敏感性一致。出院活动与3个月和12个月时PH和MH的预测一致。共病负担、就业状况、被调查者类型(代理与患者)和出院目的地与promise -10相关,特别是在12个月的MH中。结论:PH组和MH组之间的预测因子和轨迹存在差异,支持单独评估。通过区分身体和心理维度,promise -10在12个月时对轻度残疾表现出更好的区分能力,支持量身定制的护理基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.00
自引率
4.00%
发文量
583
审稿时长
62 days
期刊介绍: The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书